Balchem Corporation
BCPCStock
$166.23+3.30%52W
Market Cap$5.34B
P/E34.47x
Div yield0.59%
Beta0.81
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-4.28%
Price vs S&P 500 (4W)-1.49%
VGM Score48.15
Market Capitalization$5.34B
P/E Ratio (Annual)34.47x
Indicated Dividend Yield (Annual)0.59%
Earnings Surprise History
Q1 261.33est. 1.36
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
4.00
4.00
4.00
4.00
Industry Peers — Chemicals(15)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
BCPCBalchem Corporation | D | C | C | $166.23 |
| SOLSSolstice Advanced Materials Inc. Common Stock | C | C | D | $58.24 |
| PRMPerimeter Solutions, Inc. | D | B | B | $34.85 |
| CCThe Chemours Company | C | D | C | $17.33 |
| NGVTIngevity Corporation | C | C | B | $75.17 |
| OLNOlin Corp. | A | C | C | $21.98 |
| HUNHuntsman Corporation | B | C | C | $11.86 |
| IOSPInnospec Inc. | B | C | B | $85.46 |
| FMCFMC Corporation | A | D | D | $11.44 |
| ECVTEcovyst Inc. | B | C | C | $12.88 |
| SLIStandard Lithium Ltd. | — | — | D | $2.16 |
About
Balchem manufactures specialty performance ingredients using proprietary microencapsulation and chelation technologies. The company operates three business segments—Human Nutrition and Health (its largest), Animal Nutrition and Health, and Specialty Products—offering choline-based nutrients, mineral amino acid chelates, and specialty chemicals to diverse end markets. Balchem generates the majority of its revenue in the United States, with additional international sales.